{"id":"W4412925033","doi":"10.3389/fonc.2025.1605282","title":"Nivolumab plus cabozantinib in metastatic renal cell carcinoma: real-world evidence from the international ARON-1 study","year":2025,"lang":"en","type":"article","venue":"Frontiers in Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Institute of Cancer Research","funders":"","keywords":"Cabozantinib; Nivolumab; Medicine; Renal cell carcinoma; Oncology; Internal medicine; Performance status; Kidney cancer; Progression-free survival; Cohort; Urology; Overall survival; Cancer; Immunotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01663119,0.0006761862,0.001404939,0.0006595633,0.0002644256,0.001560885,0.0008238441,0.0006820295,0.002388665],"category_scores_gemma":[0.01566288,0.0002805548,0.002954795,0.00119301,0.000731995,0.0006963623,0.0005693335,0.001223158,0.0003402809],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00124292,"about_ca_system_score_gemma":0.001417755,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001595483,"about_ca_topic_score_gemma":0.003093464,"domain_scores_codex":[0.9912007,0.006279833,0.0008243333,0.0006020338,0.0008593531,0.0002337242],"domain_scores_gemma":[0.9711705,0.01359326,0.01085321,0.001786263,0.001620859,0.0009758737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.3895816,0.00440806,0.2969245,0.02299099,0.07327458,0.0002937166,0.0004868833,0.003322161,0.002139044,0.0006850092,0.004939014,0.2009546],"study_design_scores_gemma":[0.1401006,0.1003293,0.5778561,0.01141932,0.1230659,0.001750065,0.0008061617,0.002826014,0.002859506,0.001214987,0.03753136,0.0002406684],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7648175,0.2239151,0.0005600961,0.001900509,0.0002143319,0.0006872619,0.00336811,0.00002177105,0.004515314],"genre_scores_gemma":[0.965324,0.02995866,0.0005809615,0.0007913734,0.0003859708,0.0002002732,0.002542253,0.00001155282,0.0002048135],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01663119,"threshold_uncertainty_score":0.08795518,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0394263623607299,"score_gpt":0.3353229784516191,"score_spread":0.2958966160908892,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}